{"id":"depreotide","rwe":[{"pmid":"38132381","year":"2023","title":"Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.","finding":"","journal":"Current oncology (Toronto, Ont.)","studyType":"Clinical Study"},{"pmid":"32548796","year":"2021","title":"The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.","finding":"","journal":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","studyType":"Clinical Study"},{"pmid":"27182079","year":"2016","title":"Modeling the respiratory motion of solitary pulmonary nodules and determining the impact of respiratory motion on their detection in SPECT imaging.","finding":"","journal":"IEEE transactions on nuclear science","studyType":"Clinical Study"},{"pmid":"24668640","year":"2014","title":"Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.","finding":"","journal":"Annals of nuclear medicine","studyType":"Clinical Study"},{"pmid":"24465589","year":"2014","title":"The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.","finding":"","journal":"PloS one","studyType":"Clinical Study"}],"tags":[{"label":"depreotide","category":"class"},{"label":"Peptide","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["depreotide"],"offLabel":[],"synonyms":["depreotide"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Peptide","drugClass":"depreotide","explanation":"Think of depreotide like a key that fits into a lock. When it binds to its target, it can help to turn off or reduce the activity of certain processes in the body. This can help to treat conditions where these processes are overactive or problematic.","oneSentence":"Depreotide works by binding to a specific target, although its exact mechanism of action is unknown.","technicalDetail":"Depreotide is a synthetic peptide that acts as a somatostatin receptor subtype 2 (SSTR2) ligand, although its exact mechanism of action and pharmacokinetic properties are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2954","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DEPREOTIDE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DEPREOTIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:33:44.064473","biosimilars":[],"competitors":[],"genericName":"depreotide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03801564","phase":"NA","title":"Knee Osteoarthritis: Platelet Rich Plasma or Hyaluronic Acid","status":"UNKNOWN","sponsor":"Antalya Training and Research Hospital","startDate":"2019-01-07","conditions":["Knee Osteoarthritis"],"enrollment":120,"completionDate":"2020-03-07"},{"nctId":"NCT03931824","phase":"NA","title":"Efficacy Of Platelet Rich Plasma In The Treatment Of Hemiplegıc Shoulder Pain","status":"COMPLETED","sponsor":"Ege University","startDate":"2015-01-07","conditions":["Shoulder Pain","Shoulder Impingement","Hemiplegia, Infantile","Shoulder Subluxation","Spasticity, Muscle"],"enrollment":55,"completionDate":"2015-11-18"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"NDP0H8E844","INN_ID":"7800","UMLSCUI":"C1531556","ChEMBL_ID":"CHEMBL1908335","KEGG_DRUG":"D03687","DRUGBANK_ID":"DB11628","PUBCHEM_CID":"9898619","SNOMEDCT_US":"413971007"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":86,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2023 Nov 30","pmid":"38132381","title":"Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.","journal":"Current oncology (Toronto, Ont.)"},{"date":"2021 Feb","pmid":"32548796","title":"The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.","journal":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"date":"2016 Feb","pmid":"27182079","title":"Modeling the respiratory motion of solitary pulmonary nodules and determining the impact of respiratory motion on their detection in SPECT imaging.","journal":"IEEE transactions on nuclear science"},{"date":"2014 Jun","pmid":"24668640","title":"Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.","journal":"Annals of nuclear medicine"},{"date":"2014","pmid":"24465589","title":"The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.","journal":"PloS one"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"DEPREOTIDE","companyName":"","companyId":"","modality":"Recombinant protein","firstApprovalDate":"","aiSummary":"Depreotide is a protein modality. It has been studied in clinical trials for various conditions, including knee osteoarthritis, shoulder pain, and hemiplegia, in combination with platelet-rich plasma treatment or hyaluronic acid treatment.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"withdrawn","approval_date":"2000-11-29T00:00:00.000Z","mah":"CIS bio international","brand_name_local":"NeoSpect","application_number":"EMEA/H/C/000263"},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"NeoSpect","application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}